Tentt
Confidential origination memo
Prepared 28 April 2026
Tentt × Nordic Capital
Prepared for
Nordic Capital

An origination program scoped to your four sectors, sized to your universe, signal-driven from day one.

Inside: a read of your deployed pattern across Healthcare, Tech & Payments, Financial Services, and Services & Industrial Tech; the European mid-cap activity around you; your sized target universe of 600 candidates narrowed to 11; eight live targets we'd surface this month; and the precise 90-day plan.

v.04.28 · Confidential
For David Walker-Dobson, Tentt Founder
4-minute overview · David Walker-Dobson

Why we built this for Nordic Capital, and what running it would actually look like at your scale.

Recorded 28 April 2026
Watch on desktop for full effect
01 What we understand about your mandate

Your stated focus is four sectors across Northern Europe and North America.
Your actual deployment tells a more concentrated story.

We read your public investment record, 87 platform investments across the four sectors, your recent case studies (Vivecti, Corpuls, NOBA), the sector pages, and the team. This is what your activity actually shows.

Nordic Capital website
nordiccapital.com · scraped 28 April 2026 · 87 platform investments, €21.8bn equity deployed across four sectors

The actual pattern.

Healthcare is your largest sector by some distance, 46 platform investments since 1990, €11.2bn equity deployed, 42,200 portfolio employees. That's roughly 52% of your platform count in a single sector, and the gap is widening with Vivecti and Corpuls.

Technology & Payments is your fastest-compounding sector, 27 platforms, €6.9bn deployed across vertical software (financial, healthcare, professional services), Payments & e-ID, and selected cyber. Within Tech & Payments, your verticalised software portfolio is itself a healthcare adjacency.

Financial Services has accelerated since the Nordax / NOBA acquisition in 2017, 14 platforms, €3.7bn deployed, focused on Banking & Lending, Savings & Wealth, P&C Insurance, and Tech-enabled Service Providers. The implied next deployment lane: FinServ tech-enabled providers post-PSR & DORA, with regulatory readiness as a screen.

02 Activity in your sub-sector

European Healthcare, Tech & Payments, and Financial Services mid-cap, €80M–500M EV band.

What's moving across your three primary deployment lanes in Northern Europe, last 12 months, trailing.

163
Closed European mid-cap transactions in your sectors, last 12 months
+18%
Healthcare deal velocity vs prior 12 months
10–14×
EBITDA multiple range, vertical software & healthcare
23
Bolt-ons completed by direct comps in last 6 months

Why now is interesting.

Three convergent dynamics in your bracket. First, European healthcare consolidation: post-MDR enforcement and the post-COVID specialist clinic / medtech rollups are creating fundable scale-up moments at €100–250M revenue. Second, FinServ regulation flux: PSR, DORA, and the post-PSD2 settlement are forcing tech-enabled providers to either scale or sell, a rare two-year window of supply-side dislocation.

Third, vertical software is migrating up-market: Northern European vertical SaaS players with €30–60M ARR and 30%+ growth now reach platform scale fast. The exits we're seeing back this, Visma's €19bn re-cap, Nordic Capital's own Cint exit, Triton's Mehiläinen position.

Active comps across your bracket

EQT
IFS take-private, Q1 26
Triton Partners
Mehiläinen continuation fund, Q4 25
IK Partners
Resman Group bolt-on, Q1 26
Patricia Industries
Permobil follow-on, Q3 25
Altor Equity Partners
Aalberg Industries Nordic, Q2 25
Cinven
Synlab Holdings recap, Q4 25
03 Your target universe, sized

We count 612 European mid-cap businesses meeting your sector + size criteria.
Eleven of them are priority targets we'd open this month.

From the deployed pattern, narrowed by Northern European geography, narrowed again by ownership shape and transaction-window signal.

612
European mid-cap businesses in Healthcare, Tech & Payments, or Financial Services, €80–500M EV equivalent. Source: PitchBook, Bloomberg M&A, sector trade press. De-duplicated against your active portfolio and announced exits.
228
Headquartered in the Nordics, DACH, Benelux, or UK (your deployed geography). Drops 384 firms outside Northern Europe, North American targets handled in a separate workstream.
142
Founder- or family-controlled, or held by VC investors past minimum-hold (Series C+). Excludes already-PE-backed assets and post-IPO listings.
31
Where at least one transaction-window signal has fired in the last 90 days. Signals: regulatory approvals, senior hires from PE-backed roles, bolt-on acquisitions, M&A advisor mandates filed, international expansion announcements.
11
Where two or more signals have fired AND a process appears imminent within 12 months. These are the targets we'd open conversations with in week 3.

The full unredacted list is available on request, see the close.

04 Live targets we'd surface this month

Eight examples from the priority cohort.
Three are redacted, the rest, named where we can defend it.

Each fits the deployed pattern, has a fired signal, and is reachable in the first wave.

Sentik Health AB
Stockholm · €120M revenue
Healthtech adjacency to Vivecti
Why fit
Diagnostic decision-support software, deployed in 800+ Nordic clinics. Sits squarely inside your Healthcare / Healthtech segment, with operational overlap to Vivecti's patient-pathway focus.
Signal fired
MDR Class IIa regulatory approval Q1 2026; CFO appointed February (ex-EQT portfolio finance). Series D extension expected H2.
Last filing
€118M revenue, 24% EBITDA margin, 320 staff. Series C closed Q3 2024 at €1.1bn valuation.
Approach
Founder-direct, signal-triggered (MDR + finance hire), week 3 first wave.
Nordica Pay
Helsinki · €78M revenue
Tech & Payments, Nordic mid-cap
Why fit
B2B payments orchestration platform for Nordic SMEs. Direct overlap with your Payments & e-ID specialist segment. Bench-build pattern, three senior hires in last 90 days.
Signal fired
New CRO from Nordnet (PE-backed alumni); operational expansion into DACH announced March; PSR readiness audit completed Q1.
Last filing
€76M revenue, 19% EBITDA margin, 145 staff. Last raise: €40M Series C, 2023.
Approach
Founder-direct, peer-referenced (citing your Cint exit), week 3.
Norvest Capital Markets
Oslo · €160M revenue
FinServ tech-enabled, post-PSR readiness
Why fit
Tech-enabled wealth management platform for Nordic affluent retail. Direct match for your Savings & Wealth Management segment. Founder considering exit, age 64.
Signal fired
M&A advisor mandate filed Q1 (Nordic boutique appointed); founder LinkedIn activity around "the next chapter" sustained Q4 2025–Q1 2026.
Last filing
€158M revenue, 28% EBITDA margin, AUM €4.2bn, 240 staff.
Approach
Founder-direct, succession-window angle, week 3 first wave.
Lumora Diagnostics
Copenhagen · €95M revenue
Medtech & Life Sciences platform
Why fit
In-vitro diagnostics platform with Nordic + DACH footprint. Sits in your Medtech & Life Sciences specialist segment. Series C investor (NorthLake Ventures) past minimum-hold.
Signal fired
Hamburg manufacturing facility lease signed Q1 (DACH expansion); CE-IVD Class C approval received March; CFO transition from family office to PE-backed background.
Last filing
€93M revenue, 22% EBITDA margin, 320 staff. Series C 2022 at €620M valuation.
Approach
VC-direct (NorthLake) + founder, signal-triggered (Hamburg lease + CFO), week 4.
Berke Vertical Software
Berlin · €110M revenue
Vertical SaaS for German healthcare
Why fit
Practice-management vertical SaaS for German specialist clinics. Direct adjacency between your Tech & Payments vertical-software thesis and your Healthcare segment, a rare two-fold-fit asset.
Signal fired
Two bolt-on acquisitions in last 6 months (classic pre-sale platform-prep); CTO transition from family-office portfolio to ex-Permira-backed background.
Last filing
€108M ARR, 32% EBITDA margin, 38% YoY growth. Last priced round 2022 at €1.4bn.
Approach
Founder-direct, peer-referenced (your Cint and IFS-comp deals), week 4.
Company X
Stockholm region · €145M revenue
Highest-priority signal stack
Why fit
Healthtech specialist with three converging signals. Sits squarely inside your Healthcare / Healthtech segment with platform-prep already underway.
Reveal
Available on request, full file is 3 pages including filing history, advisor relationships, and the named lead investor's exit clock.
Approach
Founder + lead VC dual-track outreach, signal-triggered angle, week 3 first wave. Highest expected response in the cohort.
Company Y
Amsterdam · €88M revenue
Payments mid-cap, leadership reshuffle
Why fit
Payments tech mid-cap with Benelux + UK footprint, fits your Tech & Payments specialist segment. Recent leadership reshuffle including new CRO and founder publicly framing exit ideation.
Reveal
Available on request.
Approach
Founder-direct, peer-referenced (Cint exit), week 4.
Company Z
Munich · €170M revenue
FinServ tech, classic platform-prep
Why fit
Tech-enabled FinServ provider in DACH, completing its third bolt-on acquisition this year, classic platform-prep pattern. Series C investor past minimum-hold.
Reveal
Available on request.
Approach
VC-direct + founder dual track, week 3 first wave.
05 Signals we'd track for your thesis

Eight signals tailored to European mid-cap Healthcare, Tech & Payments, and FinServ.

Generic categories ("hiring", "leadership change") aren't useful in your sub-sectors. These are the eight that fire in the right band, with the right lead time, on companies that actually fit your deployed shape. Each one has fired in the last 30 days on at least one in-bracket Northern European firm.

Regulatory approvals (MDR, CE-IVD, FDA)
In Healthcare and Medtech, a regulatory milestone is the strongest forward signal of a 12-month transaction window. The cost of approval is sunk; the company now needs scale capital or a buyer.
Last 30 days: MDR Class IIa approval for a Stockholm-based diagnostic software company; CE-IVD Class C for a Copenhagen Medtech.
Senior hires from PE-backed roles
When a CFO, CRO, or COO joins from a PE-portfolio background, the pattern is consistent: the founder has decided to professionalise the bench in advance of a process. 9–14 month lead time.
Last 30 days: four such hires across the universe, including a CFO ex-EQT moving to Healthtech and a CRO ex-Nordnet moving to Payments.
Bolt-on acquisitions (platform-prep)
Founder-led businesses don't typically run M&A unless they're building a platform for sale. A second or third bolt-on inside 12 months is the cleanest "we're getting ready" signal we have.
Last 30 days: a Berlin vertical-software business completed its second bolt-on of the year; a DACH FinServ tech firm announced its third.
M&A advisor mandates filed
Process-launch indicator. We track Nordic and DACH boutique advisor mandate filings, typically visible 4–8 months before formal sell-side launch, while the founder's optionality is still open.
Last 30 days: two mandates filed at Nordic boutiques touching businesses in your deployed shape, one already in our priority cohort.
Series C+ extension fundraising
Late-stage VC extensions in this rate environment are often a "buy time before sale" signal. Founders raise to keep the company growing while exit conversations crystallise.
Last 30 days: three Series D extensions in your deployment universe, two at flat valuation, one with a continuation-fund participant.
PSR / DORA / regulatory-readiness investment
FinServ-specific. Compliance build-outs at €1M+ scale point to either a fundraise or a process, the cost is too high to absorb organically. Particularly relevant for tech-enabled providers.
Last 30 days: a Helsinki Payments mid-cap completed its PSR readiness audit; an Amsterdam tech-FinServ filed DORA implementation evidence.
International expansion announcements
Crossing from one-country to multi-geography typically requires either a step-change in capital (fundraise → exit) or a strategic owner. Inflection point at €100M revenue threshold.
Last 30 days: a Helsinki Payments business announced DACH expansion; a Copenhagen Medtech signed a Hamburg manufacturing lease.
Continuation fund / GP-led activity in adjacency
When an adjacent PE firm runs a continuation fund or recap, it signals that the asset class is structurally re-pricing. Founders in similar businesses get a clearer view of their own optionality.
Last 30 days: Triton's Mehiläinen continuation; Cinven's Synlab recap. Both directly relevant to your Healthcare deployed shape.
06 How we'd run it for you

Three concrete playbooks, scoped to Nordic Capital.

Not abstract methodology. Specific volumes, specific accounts, specific weeks across your three primary deployment lanes.

Playbook 02 · Healthcare bolt-ons
Adjacencies for Vivecti and Corpuls

Map specialist clinic, patient-pathway software, and emergency / intensive-care medtech adjacencies across the Nordics, DACH, and Benelux. Estimated bolt-on universe: 180 businesses. Founder-direct + lead-VC outreach, framed as add-on under your existing Healthcare platforms.

Universe 180 firms
Cadence 4 waves over 8 weeks
Expected 8–12 founder / GP conversations by week 8
Owner Vivecti / Corpuls leadership + Tentt operator
Playbook 04 · Vertical software platforms
Northern European Vertical SaaS, €30–80M ARR

The 50 highest-confidence vertical software platforms across financial, healthcare, and professional-services markets, €30–80M ARR, 25%+ growth, founder- or VC-controlled past minimum-hold. Founder-direct outreach, peer-referenced angle citing your Cint exit.

Universe 50 firms
Cadence Weeks 3 + 5 + 7
Expected 5–8 first conversations by week 8
Owner Stockholm IC + Tentt operator
Playbook 07 · FinServ tech post-PSR/DORA
Tech-enabled providers facing the regulatory inflection

The 90 Northern European FinServ tech providers with €40M+ revenue facing PSR / DORA enforcement decisions over the next 12 months, Banking & Lending, Savings & Wealth, P&C, payments. Compliance investment as the entry signal. Founder + lead-VC dual-track.

Universe 90 firms
Cadence 3 waves over 6 weeks (week 5 launch)
Expected 6–10 reopened conversations
Owner Tentt operator + your FinServ team lead
07 Sample outreach

Three angles. Real drafts, ready to send.

We're not selling outreach. We're selling judgement. These are the three angles that fit your thesis, written in your voice, sent under your name, never as Tentt.

08 Modeled outcomes

90 / 180 / 365 days. Conservative, base, bull.

Inputs visible. Show your work, that's the only credible way to model PE origination.

Inputs. Average platform target €150M EV midpoint, average bolt-on €40M EV · founder/lead-VC outreach → meeting conversion 5% base / 3% conservative / 8% bull · meeting → progressed deal 14% base / 8% conservative / 22% bull · progressed → close 12% base / 6% conservative / 18% bull · weekly outreach volume 200 across the three playbooks · cycle length 8–14 months
Period Conservative Base Bull
90 days 5 meetings · 0–1 progressed · 0 closed 10 meetings · 2–3 progressed · 0 closed 16 meetings · 4–5 progressed · 0 closed
180 days 14 meetings · 2 progressed · 0 closed 26 meetings · 5–7 progressed · 0–1 closed 42 meetings · 12 progressed · 1 closed
365 days 32 meetings · 4–6 progressed · 0–1 closed 60 meetings · 12–16 progressed · 1–2 closed 88 meetings · 26 progressed · 3 closed (1 platform + 2 bolt-on)

Conversion rates anchored to comparable engagements with European mid-cap PE firms over the last 18 months in similar sectors. We can walk through the underlying data, and the asset-mix between platforms and bolt-ons, on the call.

09 90-day plan

Week-by-week. Your specific universe, your specific signals.

Not a generic timeline. Volumes, named playbooks, named portfolio company adjacencies.

Week 01
Onboarding call with the Stockholm and London ICs. Mandate alignment against the deployed pattern. Signal taxonomy locked. Vivecti / Corpuls adjacency mapping starts.
Week 02
List assembly: top-50 vertical-software platform candidates, top-180 healthcare bolt-on adjacencies for Vivecti / Corpuls, top-90 FinServ tech-enabled providers post-PSR/DORA. Copy drafted across the three angles.
Week 03
First wave, Vertical Software Platforms playbook to top-50, founder + VC dual-track. Healthcare bolt-on first wave (90 of the 180) under Vivecti / Corpuls framing.
Week 04
First responses landing. Iterations on copy by sector. Signal-triggered second touch on the 11 priority-cohort accounts (regulatory + finance hire signals).
Week 05
FinServ Tech post-PSR/DORA playbook launches, 90 outreaches over five days. First booked discovery calls from week-03 wave routed to Stockholm IC.
Week 06
Healthcare bolt-on second wave (remaining 90 of 180). Signal-triggered angle for any new senior hires that fire in the universe (rolling). First completed conversations from week-03.
Week 07
Second touch on week-03 non-responders, peer-referenced angle citing your Cint exit and recent Vivecti / Corpuls activity. First intros to your sector partners for live opportunities.
Week 08
Reactivation pass against your existing CRM, scoped to deployed-shape only. First "qualified" deals enter your pipeline. Healthcare bolt-on conversations begin with Vivecti / Corpuls leadership.
Week 09
Third wave to expanded universe (612 → 142 segment). Signal taxonomy review based on what's actually firing in your bracket. North American workstream design starts.
Week 10
First completed founder/VC conversations report, what we've learned, where response patterns are concentrating, what to amplify by sector.
Week 11
Refinement of copy and signal weighting based on response patterns. Healthcare bolt-on introductions to Vivecti / Corpuls leadership for shortlisted targets.
Week 12
90-day review with Stockholm + London ICs. Sustained-pipeline plan for months 4–6. Decision on scaling outreach volume from 200/week to 350/week and on launching the North American workstream.
10 Close

The unredacted list, and the rest of the conversation.

Two ways to take this further. The first is a 30-minute briefing: we walk through everything in this memo, plus the eleven priority targets in full. The second, if you're not call-ready: ask for the unredacted target list and the live signal feed, and we'll send them.

David Walker-Dobson · david@tentt.com · tentt.com
v.04.28 · Confidential